Lactulose Hexal (Lactulose)

Lactulose is a non‑absorbable sugar that reaches the colon unchanged. Colonic bacteria ferment it into short‑chain fatty acids, which lower the pH and create an osmotic gradient that draws water into the lumen, softening stool. The acidic environment also converts ammonia to ammonium, decreasing its systemic absorption.

The dose of Lactulose Hexal is individualized by the prescribing healthcare professional based on the patient’s condition, severity, age, renal function and response. No fixed regimen is provided here; the prescriber will adjust the amount to achieve the desired clinical effect while monitoring tolerance.

Safety data for lactulose in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lactulose is an osmotic laxative, differing from stimulant laxatives such as bisacodyl, which increase intestinal motility. Osmotic agents draw water into the colon without stimulating muscle contractions, making them useful for patients who need gentle, sustained relief and for those with hepatic encephalopathy, where reducing ammonia is essential.

Lactulose Hexal should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture and direct sunlight to maintain stability and potency throughout its shelf life.

Lactulose Hexal is taken orally, usually as a liquid solution. It is mixed with water or another suitable beverage and consumed according to the prescriber’s instructions, typically once or twice daily, with the dose adjusted based on clinical response.

The most serious risks include severe dehydration, electrolyte disturbances such as hyponatremia or hypokalemia, and rare allergic reactions that may present as rash, itching or swelling. Patients should seek medical attention if they experience persistent diarrhea, dizziness, or signs of an allergic response.

Lactulose Hexal should be avoided in individuals with known hypersensitivity to lactulose, in patients with intestinal obstruction or severe gastrointestinal blockage, and in those for whom the osmotic effect could exacerbate existing electrolyte imbalances without appropriate monitoring.